A case of primary COVID-19 pneumonia: plausible airborne transmission of SARS-CoV-2원발성 COVID-19 폐렴 사례: SARS-CoV-2의 그럴듯한 공기 전파Case Reports Published on 2022-04-042022-09-11 Journal: European Journal of Medical Research [Category] COVID19(2023년), SARS, 치료기술, [키워드] absence addition Admission aerosol Aerosols Airborne transmission airway alveolar anatomical Bioaerosols Bronchoalveolar lavage bronchoscopy Cholecystitis clearance contagious COVID-19 COVID-19 pneumonia CT scan detect Diagnosis diagnosis of COVID-19 different clinical manifestations Efficacy Evidence Ground glass opacity highlight increase in Infection limitation lower lobe lower respiratory system lung infiltrate nasal Patient Pneumonia positive qPCR right lower lobe RT-qPCR Saliva salivary SARS-CoV-2 Spread Swab Test tested Transmission transmission of SARS-CoV-2 upper airway upper respiratory upper respiratory tract Variability Viral load viral replication virus zone [DOI] 10.1186/s40001-022-00668-1 PMC 바로가기 [Article Type] Case Reports
Influence of immune escape and nasopharyngeal virus load on the spread of SARS-CoV-2 Omicron variantSARS-CoV-2 오미크론 변이체의 확산에 대한 면역 탈출 및 비인두 바이러스 부하의 영향Article Published on 2022-04-012022-09-11 Journal: The Journal of Infection [Category] COVID19(2023년), SARS, 변종, [키워드] Abstract COVID-19 Immune escape influence nasopharyngeal omicron Omicron variant SARS-CoV-2 Spread vaccination variant Viral load virus load [DOI] 10.1016/j.jinf.2022.01.036 PMC 바로가기 [Article Type] Article
RNA viral loads of SARS-CoV-2 Alpha and Delta variants in nasopharyngeal specimens at diagnosis stratified by age, clinical presentation and vaccination status진단 시 비인두 표본에서 SARS-CoV-2 알파 및 델타 변이체의 RNA 바이러스 로드는 연령, 임상 증상 및 백신 접종 상태에 따라 계층화됩니다.Article Published on 2022-04-012022-09-11 Journal: The Journal of Infection [Category] COVID19(2023년), SARS, 변종, [키워드] Abstract age B.1.1.7 B.1.1.7 variant B.617.2 variant COVID-19 delta variant Diagnosis nasopharyngeal specimen respiratory tract RNA SARS-CoV-2 SARS-CoV-2 RNA SARS-CoV-2 RNA load stratified upper upper respiratory tract vaccination variant Viral load [DOI] 10.1016/j.jinf.2021.12.018 PMC 바로가기 [Article Type] Article
Viral loads and profile of the patients infected with SARS-CoV-2 Delta, Alpha, or R.1 variants in TokyoArticle Published on 2022-04-012023-07-02 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, [키워드] COVID-19 delta variant melting curve analysis SARS-CoV-2 Viral load [DOI] 10.1002/jmv.27479 PMC 바로가기
Cost-effective proactive testing strategies during COVID-19 mass vaccination: A modelling studyResearch article Published on 2022-04-012022-10-05 Journal: The Lancet Regional Health - Americas [Category] 유전자 메커니즘, [키워드] acceleration Administered Case isolation center China Commission condition Control Cost effectiveness cost-effectiveness Council COVID-19 COVID-19 pandemic effective epidemiological European finding foundation Frequency funding identify immunized Impact individual initial Innovation Isolation Local mass mitigate modelling natural partial immunity positive prevention proportion risk SARS-CoV-2 SARS-CoV-2 testing SARS-CoV-2 transmission SARS-CoV-2 vaccination SARS-CoV-2 vaccine Science sequence Stage technology Testing Transmission transmission rate vaccination variants Viral load [DOI] 10.1016/j.lana.2021.100182 [Article Type] Research article
Amplification-free detection of SARS-CoV-2 using gold nanotriangles functionalized with oligonucleotides올리고뉴클레오티드로 기능화된 금 나노삼각형을 사용한 SARS-CoV-2의 증폭 없는 검출Article Published on 2022-04-012022-09-11 Journal: Mikrochimica Acta [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] addition Alpha amplification Amplification-Free Detection AuNTs Azure Beta biosensor characterized COVID-19 patient COVID-19 patients Delta detect Detection limit develop DNA equipment Gamma gold gold standard growth infective Nasopharyngeal swab nasopharyngeal swab sample Nasopharyngeal swab samples non-infected oligonucleotide omicron Patient platform Point mutation point mutations probe Result RNA sequence RNA sequences RT-qPCR SARS-CoV-2 SARS-CoV-2 genome SARS-CoV-2 variant Viral load [DOI] 10.1007/s00604-022-05272-y PMC 바로가기 [Article Type] Article
Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines중증급성호흡기증후군 코로나바이러스 2 벡터 및 mRNA 기반 백신 접종 후 3차 병원 직원 중 접종 후 감염Observational Study Published on 2022-04-012022-09-11 Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), SARS, 변종, 임상, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Administered administration Alpha variant analysed Antigen B.1.1.7 B.1.351 B.1.617.2 Beta Beta variant BNT162b2 Breakthrough infection breakthrough infections Care ChAdOx1 ChAdOx1-S cohort study coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 death defined Delta delta variant demographic data dose effective first dose follow-up period hazard ratio hazard ratios hospital Hospital employees Hospitalization incidence Infection mRNA mRNA-based vaccine mRNA-based vaccine. not differ Observational cohort study Participants positive PCR positive PCR test postvaccination Postvaccination infection reported respiratory specimen retrospective retrospective observational cohort study RNA SARS-CoV-2 SARS-CoV-2 vaccine second dose severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 specimen vaccination Vaccination Status Vaccine vaccine dose vaccine doses variant Vector-based vaccine Viral load virus variants [DOI] 10.1016/j.cmi.2021.11.023 PMC 바로가기 [Article Type] Observational Study
Immune treatment in COVID-19COVID-19의 면역 치료Review Published on 2022-04-012022-09-11 Journal: Revista española de quimioterapia : publicación [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] apparition bamlanivimab Casirivimab cells clinical benefit Combination convalescent plasma COVID-19 current doses etesevimab Evolution exhibited Imdevimab immune knowledge mAb mAbs Meta-analysis meta-analysis and systematic review monoclonal antibodies monoclonal antibody Neutralizing activity omicron Omicron variant Patient progression Recombinant protein recombinant proteins reduction in reported retained SARS-CoV-2 serological shown Sotrovimab Standard of care systematic review target population the disease Treatment variant variants Viral Viral load viral replication [DOI] 10.37201/req/s01.14.2022 PMC 바로가기 [Article Type] Review
Development of Receptor Binding Domain (RBD)-Conjugated Nanoparticle Vaccines with Broad Neutralization against SARS-CoV-2 Delta and Other VariantsSARS-CoV-2 Delta 및 기타 변이체에 대한 광범위한 중화를 갖는 수용체 결합 도메인(RBD)-접합 나노입자 백신의 개발Article Published on 2022-04-012022-09-11 Journal: Advanced Science [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] B.1.617.2 Beta Breakthrough infection breakthrough infections cross-protective Delta delta variant Delta variants develop development dominant hACE2 Incubation period induce Infection mice NAb NAbs nanoparticle nanoparticle vaccines. Neutralizing antibodies neutralizing antibody notable omicron Omicron variant Other PROTECT Receptor binding domain recipients rhesus macaque rhesus macaques robust SARS-CoV-2 SARS-CoV-2 delta SARS-CoV-2 variant SARS-CoV-2 variants significantly strain Strains Transmission trivalent Vaccine Vaccines variant Viral Viral load VoC [DOI] 10.1002/advs.202105378 PMC 바로가기 [Article Type] Article
ALVR109, an off-the-shelf partially HLA matched SARS-CoV-2-specific T cell therapy, to treat refractory severe COVID-19 pneumonia in a heart transplant patient: Case report심장 이식 환자의 난치성 중증 COVID-19 폐렴을 치료하기 위해 부분적으로 HLA와 일치하는 기성품인 SARS-CoV-2-특이적 T 세포 요법인 ALVR109: 사례 보고Case Reports Published on 2022-04-012022-09-11 Journal: American journal of transplantation : official jou [Category] COVID19(2023년), SARS, 변종, [키워드] Administered administration antibiotic: antiviral Antiviral benefit Cell therapy Clinical improvement clinical research/practice clinical trials Corticosteroids COVID-19 Day declined delta variant diagnosis of COVID-19 discharged Heart transplantation heart transplantation/cardiology High-flow nasal oxygen HLA immunobiology Immunosuppression improvement IND Infection infection and infectious agents-viral: SARS-CoV-2/COVID-19 infectious agents Infectious disease initial log low-flow oxygen male mycophenolate mycophenolate mofetil nasopharyngeal nasopharyngeal viral oxygen Patient Prednisone Quantitative rejection Remdesivir request rising RNA SARS-CoV-2 delta SARS-CoV-2 RNA Severe COVID-19 pneumonia subsequent T cell tacrolimus the patient therapy Tocilizumab transitioned treat treated undetectable variant Viral load [DOI] 10.1111/ajt.16927 PMC 바로가기 [Article Type] Case Reports